Prerequisites for the Immunotherapy of Cancer
β Scribed by Graham Pawelec; Andrea Engel; Medi Adibzadeh
- Publisher
- Springer-Verlag
- Year
- 1999
- Tongue
- English
- Weight
- 67 KB
- Volume
- 48
- Category
- Article
- ISSN
- 0340-7004
No coin nor oath required. For personal study only.
π SIMILAR VOLUMES
## Abstract ## Background To develop novel therapeutic approaches for patients with head and neck malignancies, poorly immunogenic murine models of squamous cell carcinoma (SCC) need to be defined. ## Methods The phenotype, growth characteristics, and responsiveness to tumorβspecific Tβcell tran
Intravesical therapy has been used in the management of superficial transitional cell carcinoma (TCC) of the urinary bladder (i.e., Ta, Tl, and carcinoma in situ) with specific objectives which include treating existing/residual tumor, preventing recurrence of tumor, preventing disease progression,